v1
Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group study.
Identifier:nobleid.org/w1/20260515/FDCD8433
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/FDCD8433)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims